SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC

Clinical trial NCT06925048 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06925048
Sponsor: Chunxia Su
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer JAK Inhibitor Immunology

Start date: 2025-04-30
Primary completion: 2026-12-31
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.